These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment. Azaña JM; Torrelo A; Matito A Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106 [TBL] [Abstract][Full Text] [Related]
28. Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022. Arock M; Hoermann G; Sotlar K; Hermine O; Sperr WR; Hartmann K; Brockow K; Akin C; Triggiani M; Broesby-Olsen S; Reiter A; Gotlib J; Horny HP; Orfao A; Metcalfe DD; Valent P J Allergy Clin Immunol; 2022 Jun; 149(6):1855-1865. PubMed ID: 35430191 [TBL] [Abstract][Full Text] [Related]
29. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice. Valent P; Hartmann K; Schwaab J; Alvarez-Twose I; Brockow K; Bonadonna P; Hermine O; Niedoszytko M; Carter MC; Hoermann G; Sperr WR; Butterfield JH; Ustun C; Zanotti R; Radia DH; Castells M; Triggiani M; Schwartz LB; Orfao A; George TI; Sotlar K; Gotlib J; Reiter A; Horny HP; Arock M; Akin C; Metcalfe DD J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1999-2012.e6. PubMed ID: 35342031 [TBL] [Abstract][Full Text] [Related]
30. Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors. Shomali W; Gotlib J Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804174 [TBL] [Abstract][Full Text] [Related]
31. Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future. Valent P; Akin C; Hartmann K; Nilsson G; Reiter A; Hermine O; Sotlar K; Sperr WR; Escribano L; George TI; Kluin-Nelemans HC; Ustun C; Triggiani M; Brockow K; Gotlib J; Orfao A; Schwartz LB; Broesby-Olsen S; Bindslev-Jensen C; Kovanen PT; Galli SJ; Austen KF; Arber DA; Horny HP; Arock M; Metcalfe DD Cancer Res; 2017 Mar; 77(6):1261-1270. PubMed ID: 28254862 [TBL] [Abstract][Full Text] [Related]
32. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. Gülen T; Hägglund H; Dahlén B; Nilsson G J Intern Med; 2016 Mar; 279(3):211-28. PubMed ID: 26347286 [TBL] [Abstract][Full Text] [Related]
33. Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis. Nedoszytko B; Arock M; Lyons JJ; Bachelot G; Schwartz LB; Reiter A; Jawhar M; Schwaab J; Lange M; Greiner G; Hoermann G; Niedoszytko M; Metcalfe DD; Valent P Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401724 [TBL] [Abstract][Full Text] [Related]
34. Mast cell proliferative disorders: current view on variants recognized by the World Health Organization. Valent P; Akin C; Sperr WR; Horny HP; Metcalfe DD Hematol Oncol Clin North Am; 2003 Oct; 17(5):1227-41. PubMed ID: 14560784 [TBL] [Abstract][Full Text] [Related]
35. Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KIT. Bibi S; Arock M Immunol Allergy Clin North Am; 2018 Aug; 38(3):527-543. PubMed ID: 30007468 [TBL] [Abstract][Full Text] [Related]
36. Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. Kristensen T; Vestergaard H; Møller MB J Mol Diagn; 2011 Mar; 13(2):180-8. PubMed ID: 21354053 [TBL] [Abstract][Full Text] [Related]
37. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Arock M; Valent P Expert Rev Hematol; 2010 Aug; 3(4):497-516. PubMed ID: 21083038 [TBL] [Abstract][Full Text] [Related]
38. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management. Pardanani A Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759 [TBL] [Abstract][Full Text] [Related]
39. New Insights into the Pathogenesis of Systemic Mastocytosis. Li Z Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063170 [TBL] [Abstract][Full Text] [Related]
40. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management. Pardanani A Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]